CURIS, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
CURIS, INC. (CRIS) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $100.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2017-08-03
- CURIS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2016-09-30 was $100.00K.
- CURIS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2016-06-30 was $14.00K, a 89.06% decline year-over-year.
- CURIS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2016-03-31 was -$100.00K, a 183.22% decline year-over-year.
- CURIS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2015-12-31 was $100.00K.
- CURIS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2015 was $300.00K.
- CURIS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2013 was $351.09K, a 1.16% decline from fiscal 2012.
- CURIS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2012 was $355.22K.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $100.00K 10-Q · filed 2016-11-03 | $114.00K derived: sum of 2 quarters · filed 2016-11-03 | -$100.00K 10-Q · filed 2016-11-03 | $114.00K derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2016-06-30 | $14.00K 10-Q · filed 2016-08-04 | -$100.00K 10-Q · filed 2017-08-03 | $14.00K derived: sum of 3 quarters · filed 2017-05-04 | -$86.00K derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2016-03-31 | -$100.00K 10-Q · filed 2017-05-04 | $120.16K 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2017-05-04 | -$100.00K derived: sum of 3 quarters · filed 2017-05-04 | $28.00K derived: sum of 4 quarters · filed 2017-05-04 | |||
| 2015-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-09 | $128.00K derived: sum of 3 quarters · filed 2017-03-09 | $300.00K 10-K · filed 2017-03-09 | $292.99K 10-K · filed 2016-02-29 | |||
| 2015-09-30 | -$100.00K 10-Q · filed 2016-11-03 | $28.00K derived: sum of 2 quarters · filed 2016-11-03 | $200.00K 10-Q · filed 2016-11-03 | $154.11K 10-Q · filed 2015-11-09 | ||||
| 2015-06-30 | $128.00K 10-Q · filed 2016-08-04 | $127.47K 10-Q · filed 2015-08-06 | $248.00K 10-Q · filed 2016-08-04 | $247.63K 10-Q · filed 2015-08-06 | ||||
| 2015-03-31 | $120.16K 10-Q · filed 2016-05-09 | |||||||
| 2014-09-30 | $91.97K 10-Q · filed 2014-11-10 | $91.97K 10-Q · filed 2014-11-10 | ||||||
| 2014-03-31 | $55.67K 10-Q · filed 2015-05-07 | -$87.86K derived: sum of 2 quarters · filed 2016-02-29 | $226.25K derived: sum of 3 quarters · filed 2016-02-29 | |||||
| 2013-12-31 | -$143.53K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $170.58K derived: sum of 2 quarters · filed 2016-02-29 | $351.09K 10-K · filed 2016-02-29 | |||||
| 2013-09-30 | $314.11K 10-Q · filed 2014-11-10 | $494.62K 10-Q · filed 2014-11-10 | ||||||
| 2012-12-31 | $355.22K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |